Related Experiment Video
Updated: Jul 13, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Coverage of HIV prevention programmes for injection drug users: confusions, aspirations, definitions and ways forward
Mukta Sharma1, Dave Burrows, Ricky Bluthenthal
1Department of Social Policy, London School of Economics, United Kingdom. m.sharma@lse.ac.uk <m.sharma@lse.ac.uk>
Abstract:
The concept of coverage first emerged in the 1960s as a key indicator for measuring the proportion of populations that were covered by health care. In the area of HIV interventions among injecting drug users, the term "coverage" has been used for widely different aspects of reach and effectiveness of programmes. This paper reviews an array of ways of thinking about coverage from the scientific and grey literature and discusses methods of estimating coverage, finding that some measures of coverage refer to individuals, others to populations and others to populations covered by services. Nomenclature for these various types of "coverage" are discussed and recommendations are provided for future attempts to measure coverage of harm reduction interventions.
Related Concept Videos
Sexually Transmitted Infections
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Retrovirus Life Cycles
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
